PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-May-2022 Blood Ketone Monitoring Is Expected To Be The Highest Revenue Generating Product, With A CAGR Of 9.5%, During 2022 – 2032 MARKITWIRED Latest Market Reports
10-May-2022 Rise in Hospital-acquired Infections to Fuel Demand for Medical Device Cleaning – Fact.MR Study MARKITWIRED Latest Market Reports
10-May-2022 Dermatology CRO Revenue Will Grow 2.4x From 2022 To 2032 MARKITWIRED Latest Market Reports
10-May-2022 India Static Compression Therapy Market Key Players, SWOT Analysis, Key Indicators and Forecast to 2026 MARKITWIRED
10-May-2022 Worldwide Emergency Medical Service Products Market To Reach A Market Valuation Of US$ 50 Billion By 2032 MARKITWIRED Latest Market Reports
10-May-2022 Global Market For Extremities Reconstruction Are Expected To Exceed US$ 2,000 Million By 2022-End MARKITWIRED Latest Market Reports
10-May-2022 Demand For Neurointerventional Treatment Devices Is Predicted To Increase At A Robust CAGR Of 8% Through 2031 MARKITWIRED Latest Market Reports
10-May-2022 Bone Growth Stimulators Market size is poised to reach US$ 1.8 Billion in 2022 MARKITWIRED
10-May-2022 APONTIS PHARMA continues strong profitable growth in Q1 2022 APONTIS PHARMA AG
10-May-2022 Formycon AG and ATHOS KG announce closing of transaction to acquire biosimilar assets FYB201 and FYB202 as well as Bioeq GmbH Formycon AG
10-May-2022 Demand For Newborn Screening Consumables To Expand Impressively, Growing At Approximately 8% CAGR Through 2031 MARKITWIRED Latest Market Reports
10-May-2022 Worldwide Sales Of Microplate Systems Are Valued At US$ 922.3 Million In 202 MARKITWIRED Latest Market Reports
10-May-2022 Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients Newswire
09-May-2022 Voluntary Improvement Program (VIP) Becomes the First Case for Quality Program Recognized by the FDA Businesswire
09-May-2022 Invacare Reports Results for First Quarter 2022 Businesswire
09-May-2022 Harris Williams Advises STAXS® on its Pending Sale to Franz Haniel & Cie. GmbH Businesswire
09-May-2022 Verastem Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress Businesswire
09-May-2022 Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study Businesswire
09-May-2022 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET Businesswire
09-May-2022 Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Update Businesswire